公司简介

Dotbiohk Limited

DotBioHK Limited (“DotBioHK”) is a Hong Kong-based, wholly-owned subsidiary of DotBio Pte Ltd (DotBio), a Singapore-based biopharmaceutical start-up focusing on next-generation multi-specific antibody drugs. DotBio has a proprietary humanized, stable Domain Therapeutic Antibody (“Dotbody”) technology that will revolutionize multi-specific therapies, antibody-drug conjugates and CAR-T therapies. DotBio currently possess proprietary state-of-art DotBody and Fab phage display libraries, as well as numerous pre-clinical assets in the immune-oncology field. Meanwhile, DotBioHK will has a major focus on non-oncology therapeutic areas.

以上资料仅供参考。有关园区公司的最新资讯,请以其官方公布的讯息为准。

联系我们

如有一般咨询,或有关香港科技园服务与援助计划的问题,请在下方空白处填写您的电子邮箱和咨询内容。